Kazia Therapeutics

Kazia Therapeutics(KZIA)

Australia - Sydney
Biotechnology

Focus: Clinical-stage oncology company with a lead program in US-based phase II trials for brain cancer

Kazia Therapeutics is a life sciences company focused on Clinical-stage oncology company with a lead program in US-based phase II trials for brain cancer.

OncologyNeurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT05114668Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours
Phase 1
Part A: Dose Escalation of Cantrixil
Ovarian Neoplasms
Phase 1
Clinical Trials (1)
NCT02903771Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
Phase 1
[14C]-Paxalisib Capsule
Healthy
Phase 1
Clinical Trials (1)
NCT05012670Mass Balance Recovery, Metabolite Profile, and Metabolite Identification of [14C]-Paxalisib in Healthy Male Subjects
Phase 1
Phase 1
Clinical Trials (1)
NCT04192981GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases
Phase 1
Clinical Trials (1)
NCT00022295Phenoxodiol in Treating Patients With Refractory Solid Tumors
Phase 1
Clinical Trials (1)
NCT03696355Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
Phase 1
Phase 1/2
Phase 1/2
Paxalisib
Glioblastoma
Phase 2
Clinical Trials (1)
NCT05183204Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma
Phase 2
Trastuzumab
Breast Cancer
Phase 2
Clinical Trials (1)
NCT03765983GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
Phase 2
Phase 2
Clinical Trials (1)
NCT04906096Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
Phase 2
Phase 2
Clinical Trials (1)
NCT03522298Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma
Phase 2
Temozolomide
Glioblastoma
Phase 2/3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 10 clinical trials